rais estim
investor react posit confid turnaround upsid
us knee sale help drive total sale growth cc vs cse
factset consensu investor react favor result
extend rise sentiment toward lead quarter see
investor sentiment survey recogn attract zbh below-
averag valuat given medtech out-performance ytd rel
said continu view risk/reward profil
attract even premium respect
result rais estim target stick
under-perform rate higher estim driven part inclus
robot system sale higher tp driven primarili
higher target multipl reflect higher sector market multipl
us knee lift implant rosa system sale
analysi estim amer knee implant sale declin
reflect loss share improv
declin system sale ad bp
amer knee growth estim bring total report growth
isnt ev/ebitda cheap enough us
name univers trade averag discount
ev/ebitda convers current trade premium
 vs target multipl discount
valuat tp base ev/ebitda
multipl ntm ebitda bil one year forward
unch reflect higher market sector multipl risk re-
acceler us knee implant sale faster uptak rosa knee
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
mariu zoican univers toronto rotman school manag juli
inc global manufactur provid
medic devic equip treatment
musculoskelet spinal disord trauma dental implant
price jul rate under-perform target price analyst matt miksic
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
one-year valuat scenario base
ev/ebitda ebitda
scenario base high-growth segment grow
growth grow
one-year valuat grey scenario base
ev/ebitda grey ebitda
grey scenario base high-growth segment grow
growth grow
mariu zoican univers toronto rotman school manag juli
addit detail takeaway
knee mil mil y/i cc vs cse
america knee sale mil mil increas cc emea
sale mil mil cc apac sale mil mil
increas cc growth quarter driven sale execut well new
product launch includ persona partial cementless compani continu
place rosa knee robot system limit launch phase indic
system revenu contribut report knee sale ww knee implant sale
still year year grew faster analysi
estim compani report mil rosa revenu grew
ww busi cc cc base estim believ
compani lost around share loss see figur
figur hip knee growth market share gains/loss major
growth market share analysi estimate implant sale ex-robot sale
knee growth adjust exclud estim contribut sale rosa system estim mil ad growth
figur hip knee share gains/loss major competitor
knee share exclud estim contribut rosa system sale estim mil
mariu zoican univers toronto rotman school manag juli
hip mil mil y/i cc vs cse
america hip sale mil mil increas cc emea
sale mil mil cc apac sale mil mil
set sale mil mil y/i cc vs cse spine
cmf sale mil mil decreas y/i cc vs cse dental
revenu mil mil y/i cc vs cse
sale mil mil y/i cc vs cse
geograph america sale bil mil cc emea
sale mil mil increas cc apac sale mil mil
compani updat report sale growth guidanc
flat fx expect headwind bp vs bp
previous impli cc sale growth vs previous
fx expect less impact sell day differ day
off-set one addit sell day bottom-lin increas
ep guidanc
mariu zoican univers toronto rotman school manag juli
 oper margin line estim
sale net cog partial off-set higher deliv beat
ep rel estim consensu gross margin bp
y/i bp estim compani expect gm improv driven
anticip refund prior-period medic devic excis tax impact
sale
sale
estimate
ep
sale
sale
mariu zoican univers toronto rotman school manag figur revenu summari
estimate
mariu zoican univers toronto rotman school manag juli
chang model
made minor adjust sale estim increas ep
estim made adjust top-lin project
beyond reflect robot system sale drive increas ep estim
project mil robot system sale mil mil
mil
figur chang model
mariu zoican univers toronto rotman school manag juli
compani mention price
